Earth Pharmaceutical Completes Integration with Busclin for a New Era

Earth Pharmaceutical Completes Integration with Busclin

As we welcome the New Year in 2026, Earth Pharmaceutical Co., Ltd., headquartered in Chiyoda, Tokyo, and led by President Katsunori Kawabata, is pleased to announce the successful completion of its integration with its wholly-owned subsidiary, Busclin Co., Ltd., effective January 1, 2026. This merger is part of our strategy to enhance operational efficiency and optimize resources within the group, thereby elevating the market presence of the Earth Group.

Entering its 100th year in 2025, Earth Pharmaceutical is poised for a new beginning as we look forward to the next century. The integration with Busclin, known for its strong brand in health and wellness products such as bath additives, hair regrowth solutions, and cosmetics, will significantly bolster our capabilities in product development and marketing, particularly in the bath additive category.

Earth Pharmaceutical has been dedicated to caring for everyday needs with offerings including pest control products like 'Gokiburi Hoyhoy,' 'Earth Red,' and 'Earth Nomat,' as well as oral care products like 'Mondamin.' Through this integration, we are excited to combine our strengths and exceed consumer expectations by providing innovative and high-quality products and services.

Busclin’s guiding principle of “Health Evolves” resonates with our mission of embracing life and coexisting with the planet. As a newly integrated entity, Earth Pharmaceutical is committed to contributing to the well-being and comfort of our customers, paving the way for a healthier lifestyle.

The new Earth Pharmaceutical will continue to embrace change and challenge itself to provide value that deeply connects with people’s lives around the globe. We sincerely ask for your continued support as we embark on this transformative journey.

In closing, we recognize that the path ahead will be filled with opportunities and challenges. By harnessing the combined expertise of both Earth Pharmaceutical and Busclin, we are confident in our ability to deliver superior products that resonate with our consumers. Our commitment to quality and innovation will remain at the forefront of our operations as we strive to enhance our customers' quality of life.

Let us step into this New Year with optimism and resolve, ready to forge ahead into a promising future together.